24.05.2021 22:05:00

Electromed, Inc. Named 2021 Quality Plant of the Year

Electromed, Inc. (NYSE American: ELMD) was named Quality Magazine’s 2021 Plant of the Year.

Electromed was selected for the honor from the 2021 Quality Leadership Top 100 Company survey published annually by the magazine. The metrics measure and showcase quality leadership such as: continuous improvement and internal quality programs; contribution of quality to profitability and shareholder value; average number of hours that employees receive quality training; scrap and rework as a percentage of sales; warranty costs as a percentage of sales; and registration to various standards such as ISO 9001. Electromed is certified to ISO 13485, used by organizations involved in the design, production, installation and servicing of medical devices. The Company has qualified as a top 10 company in the Quality Leadership Top 100 survey three of the last four years.

"We are so excited to be named as Quality Magazine’s 2021 Plant of the Year as this is a great honor for all of our team members and highlights their unwavering passion for patients, one of our core values,” said Kathleen Skarvan, President and Chief Executive Officer. "When you talk to our team members throughout the organization, you will hear a recurring theme: it feels good knowing that what we do makes a difference in a person’s life. With that engagement comes a recognition of the importance of delivering high quality services and a high-quality product.”

The full article, and a podcast can be found at https://bit.ly/2QpamO0.

About Electromed, Inc.

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Nachrichten zu Electromed Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Electromed Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Electromed Inc. 29,80 0,74% Electromed Inc.